113
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Enhanced tumour uptake of radiolabelled antibodies by hyperthermia. Part II: Application of the thermal equivalency equation

&
Pages 13-27 | Received 02 Jan 2004, Accepted 06 Aug 2004, Published online: 09 Jul 2009

References

  • Kong G, Dewhirst MW. Hyperthermia and liposomes: A review. Int J Hyperthermia 1999;15:345–370.
  • Needham D, Anyarambhatla G, Kong G, Dewhirst MW. New temperature-sensitive liposome for use with mild hyperthermia: Characterization and testing in a human tumor xenograft model. Cancer Res 2000;60:1197–1201.
  • Ceelen WP, Hesse U, de Hemptinne B, Pattyn P. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surg 2000;87:1006–1015.
  • Huang Q, Hu JK, Lohr F, Zhang L, Braun R, Lanzen J, Little JB, Dewhirst MW, Li CY. Heat-induced gene expression as a novel targeted cancer gene therapy strategy. Cancer Res 2000;60:3435–3439.
  • Lohr F, Hu K, Huang Q, Zhang L, Sarnulski TV, Dewhirst MW, et al. Enhancement of radiotherapy by hyperthermia-regulated gene therapy. hit J Radiat Oncol Biol Phys 2000;48:1513–1518.
  • Horsman MR, Murata R, Breidahl T, Nielsen FU, Maxwell RJ, Stodkiled-Jorgensen H, et al. Combretastatins novel vascular targeting drugs for improving anti-cancer therapy. Combretastatins and conventional therapy. Advances Exp Med Biol 2000;476:311–323.
  • Brade AM, Ngo D, Szmitko P, Li PX, Liu FF, Klamut HJ. Heat-directed gene targeting of adenoviral vectors to tumor cells. Cancer Gene Ther 2000;7:1566–1574.
  • Braiden V, Ohtsuru A, Kawashita Y, Miki F, Sawada T, Ito M, et al. Eradication of breast cancer xenografts by hyperthermic suicide gene therapy under the control of the heat shock protein promoter. Human Gene Ther 2000;11:2453–2463.
  • Tsujino I, Anderson GS, Sieber F. Postirradiation hyperthermia selectively potentiates the merocyanine 540-sensitized photoinactivation of small cell lung cancer cells. Photochem Photobiol 2000;73: 191–198.
  • Uehara M, Inokuchi T, Sano K. Experimental study of combined hyperthermic and photodynamic therapy on carcinoma in the mouse. J Oral Maxillofacial Surg 1996;54:729–736.
  • van Hillegersberg R, Kort WJ, Wilson JH. Current status of photodynamic therapy in oncology. Drugs 1994;48:510–527.
  • Baron S, Tyring SK, Fleischmann WR, Jr, Coppenhaver DH, Niesel DW, Klimpel GR, et al. The interferons. Mechanisms of action and clinical applications. JAMA 1991;266:1375–1383.
  • Mittal BB, Zimmer MA, Sathiaseelan V, Benson AB III, Mittal RR, Dutta S, et al. Phase I/II trial of combined 1311 anti-CEA monoclonal antibody and hyperthermia in patients with advanced colorectal adenocarcinoma. Cancer 1996;78: 1861–1870.
  • Hauck ML, Dewhirst MW, Bigner DD, Zalutsky MR. Local hyperthermia improves uptake of a chimeric monoclonal antibody in a subcutaneous xenograft model. Chin Cancer Res 1997;3:63–70.
  • Cope DA, Dewhirst MW, Friedman HS, Bigner DD, Zalutsky MR. Enhanced delivery of a monoclonal antibody F(Ab')2 fragment to subcutaneous human glioma xenografts using local hyperthermia. Cancer Res 1990;50: 1803–1809.
  • Hosono MN, Hosono M, Endo K, Ueda R, Onoyarna Y. Effect of hyperthermia on tumor uptake of radiolabeled anti-neural cell adhesion molecule antibody in small-cell lung cancer xenografts. J Nucl Med 1994;35:504–509.
  • Schuster JM, Zalutsky MR, Noska MA, Dodge R, Friedman HS, Bigner DD, et al. Hyperthermic modulation of radiolabelled antibody uptake in a human glioma xenograft and normal tissues. Int J Hyperthermia 1995;11:59–72.
  • Stickney DR, Gridley DS, Kirk GA, Slater JM. Enhancement of monoclonal antibody binding to melanoma with single dose radiation or hyperthermia. Natl Cancer Inst Monogr 1987;3:47–52.
  • Bourdon MA, Wikstrand CJ, Furthmayr H, Matthews TJ, Bigner DD. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res 1983;43:2796–2805.
  • Hauck ML, Coffin DO, Dodge RK, Dewhirst MW, Mitchell JB, Zalutsky MR. A local hyperthermia treatment which enhances antibody uptake in a glioma xenograft model does not affect tumor interstitial fluid pressure. hit J Hyperthermia 1997;13:307–316.
  • Jain RK, Ward-Hartley K. Tumor blood flow-characterization, modifications, and role in hyperthermia. IEEE Trans Son Ult 1984;5U31:504–526.
  • Reinhold HS, Endrich B. Tumour microcirculation as a target for hyperthermia. Int J Hyperthermia 1986;2:111–137.
  • Gridley DS, Ewart KI,, Cao JD, Stickney DR. Hyperthermia enhances localization of 111In-labeled hapten to bifunctional antibody in human colon tumor xenografts. Cancer Res 1991;51:1515–1520.
  • Hauck ML, Dewhirst MW, Zalutsky MR. The effects of clinically relevant hyperthermic temperatures on the kinetic binding parameters of a monoclonal antibody. Nucl Med Biol 1996;23:551–557.
  • Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. hit J Radiat Oncol Biol Phys 1984;10:787–800.
  • Thrall DE, Rosner GL, Azuma C, LaRue SM, Case BC, Samulski TV, et al. Using units of CEM43°CT90, local hyperthermia thermal dose can be delivered as prescribed. hit J Hyperthermia 2000;16:415–428.
  • Dewhirst MW, Vigilianti BL, Lora-Michiels M, Hanson M, Hoopes PJ. Basic principles of thermal dosimetry and thermal threshold for tissue damage from hyperthermia. Int J Hyperthermia 2003;19:267–294.
  • Kapp DS, Cox RS. Thermal treatment parameters are most predictive of outcome in patients with single tumor nodules per treatment field in recurrent adenocarcinoma of the breast. Int J Radiat Oncol Biol Phys 1995;33:887–899.
  • Maguire PD, Samulski TV, Prosnitz LR, Jones EL, Rosner GL, Powers B, et al. A phase II trial testing the thermal dose parameter CEM43°T90 as a predictor of response in soft tissue sarcomas treated with preoperative thermoradiotherapy. hit J Hyperthermia 2001;17:283–290.
  • Oleson JR, Sarnulski TV, Leopold KA, Clegg ST, Dewhirst MW, Dodge RK, et al. Sensitivity of hyperthermia trial outcomes to temperature and time: Implications for thermal goals of treatment. Int J Radiat Oncol Biol Phys 1993;25:289–297.
  • Wikstrand CJ, McLendon RE, Carrel S, Kemshead JT, Mach J.-P, Coakham HB, et al. Comparative localization of glioma-reactive monoclonal antibodies in vivo in an athymic mouse human glioma xenograft model. J Neuroimmunol 1987;15:37–56.
  • Murphy-Ullrich JE, Lighmer VA, Aukhil I, Zan YZ, Erickson HP, Hook M. Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin. J Cell Biol 1991;115:1127–1136.
  • He X, Archer GE, Wikstrand CJ, Morrison SL, Zalutsky MR, Bigner DD, et al. Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin. J Neuroimmunol 1994;52:127–137.
  • Dangl JI,, Wensel TG, Morrison SL, Stryer L, Herzenberg LA, Oi VT. Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J 1988;7:1989–1994.
  • Fraker PJ, Speck JC. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. Biochem Biophys Res Commun 1978;80:849–857.
  • Bullard DE, Schold SC, Bigner SH, Bigner DD. Growth and chemotherapeutic response in athymic mice of tumors arising from human glioma-derived cell lines. Neuropathol Exp Neurol 1981;40:410–427.
  • Hauck ML, Zalutsky MR. Enhanced tumour uptake of radiolabelled antibodies by hyperthermia: Part I: Timing of injection relative to hyperthermia. hit J Hyperthermia, in press.
  • Msirikale JS, Klein JI,, Schroeder J, Order SE. Radiation enhancement of radiolabelled antibody deposition in tumors. Int J Radiat Oncol Biol Phys 1987;13:1839–1844.
  • Wong JYC, Williams LE, Hill LR, Paxton RJ, Beatty BG, Shively JE, Beatty JD. The effects of tumor mass, tumor age, and external beam radiation on tumor-specific antibody uptake. hit J Radiat Oncol Biol Phys 1989;16:715–720.
  • Shrivastav S, Schlom J, Raubitschek A, Molinolo A, Simpson J, Horan Hand P. Studies concerning the effect of external irradiation on localization of radiolabeled monoclonal antibody B72.3 to human colon carcinoma xenografts. hit J Radiat Oncol Biol Phys 1989;16: 721–729.
  • Hauck ML, Zalutsky MR. The effects of local hyperthermia on the catabolism of a radioiodinated chimeric monoclonal antibody. Chin Cancer Res 1998;4:2071–2077.
  • Nishimura Y, Hiraoka M, Jo S, Akuta K, Yukawa Y, Shibarnoto Y, et al. Microangiographic and histologic analysis of the effects of hyperthermia on murine tumor vasculature. hit J Radiat Oncol Biol Phys 1988;15:411–420.
  • Covell DG, Barbet J, Holton OD, Black CDV, Parker RJ, Weinstein JN. Pharmacokinetics of monoclonal immunoglobulin G1, F(A1:02, and Fab' in mice. Cancer Res 1986;46:3969–3978.
  • Dewey WC. Vascular-extravascular exchange of Ils1 plasma proteins in the rat. Am J Phys 1959;197:423–431.
  • Sherar M, Liu F.-F, Pintilie M, Levin W, Hunt J, Hill R, et al. Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: Data from a phase III trial. Int J Radiat Oncol Biol Phys 1997;39:371–380.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.